Dysbiosis modulates capacity for bile acid modification in the gut microbiomes of patients with inflammatory bowel disease: a mechanism and marker of disease?

Gut. 2012 Nov;61(11):1642-3. doi: 10.1136/gutjnl-2012-302137. Epub 2012 Apr 5.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • Chenodeoxycholic Acid / analogs & derivatives*
  • Humans
  • Inflammatory Bowel Diseases / drug therapy*
  • Intestinal Absorption / drug effects*
  • Receptors, Cytoplasmic and Nuclear / physiology*

Substances

  • Receptors, Cytoplasmic and Nuclear
  • Chenodeoxycholic Acid